Faculty Opinions recommendation of Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study.

Randomized Phase 2

Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study

Liver International ◽

10.1111/liv.13192 ◽

2016 ◽

Vol 37 (1) ◽

pp. 54-61 ◽

Cited By ~ 4

Author(s):

Sirio Fiorino ◽

Elisabetta Loggi ◽

Gabriella Verucchi ◽

Donatella Comparcola ◽

Ranka Vukotic ◽

...

Keyword(s):

Chronic Hepatitis ◽

Vitamin E ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Study ◽

Phase 2 ◽

Paediatric Patients ◽

Randomized Phase 2

P1088 VITAMIN E AS THERAPY FOR CHILDREN WITH E ANTIGEN POSITIVE CHRONIC HEPATITIS B: RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Journal of Hepatology ◽

10.1016/s0168-8278(14)61248-4 ◽

2014 ◽

Vol 60 (1) ◽

pp. S440

Author(s):

S. Fiorino ◽

G. Verucchi ◽

D. Comparcola ◽

M. Pavoni ◽

E. Grandini ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Chronic Hepatitis ◽

Vitamin E ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Randomized Controlled ◽

A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol

Hepatology International ◽

10.1007/s12072-011-9294-7 ◽

2011 ◽

Vol 6 (2) ◽

pp. 441-448 ◽

Cited By ~ 8

Author(s):

Wen Xie ◽

Guangfeng Shi ◽

Hongfei Zhang ◽

Guiming Zhao ◽

Zujiang Yu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Controlled Study ◽

Hepatitis B E Antigen ◽

Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study

Journal of Hepatology ◽

10.1016/j.jhep.2016.05.024 ◽

2016 ◽

Vol 65 (4) ◽

pp. 674-682 ◽

Cited By ~ 19

Author(s):

Jian Sun ◽

Hong Ma ◽

Qing Xie ◽

Yao Xie ◽

Yongtao Sun ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Randomized Controlled Study ◽

Controlled Study ◽

Randomized Controlled ◽

Vitamin E as therapy for children with E antigen positive chronic hepatitis B: Results of a randomized controlled trial

Digestive and Liver Disease ◽

10.1016/j.dld.2014.01.115 ◽

2014 ◽

Vol 46 ◽

pp. e52

Author(s):

S. Fiorino ◽

G. Verucchi ◽

D. Comparcola ◽

M. Pavoni ◽

E. Grandini ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Chronic Hepatitis ◽

Vitamin E ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Randomized Controlled ◽

O113 COMBINATION THERAPY WITH PEGINTERFERON ALFA-2a AND A NUCLEOS(T)IDE ANALOGUE FOR HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: RESULTS OF A LARGE, RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)60115-x ◽

2014 ◽

Vol 60 (1) ◽

pp. S47 ◽

Cited By ~ 9

Author(s):

W.-W. Su ◽

C.-W. Hsu ◽

C.-M. Lee ◽

C.-Y. Peng ◽

W.-L. Chuang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Peginterferon Alfa

Tailored regimen of interferon alpha for HBeAg-positive chronic hepatitis B: a prospective controlled study

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2008.00995.x ◽

2008 ◽

Vol 15 (9) ◽

pp. 684-689 ◽

Cited By ~ 4

Author(s):

K. Luo ◽

Q. Mao ◽

P. Karayiannis ◽

D. Liu ◽

Z. Liu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Controlled Study ◽

Prospective Controlled Study

Association of Liver Fibrosis based on Transient Elastography and Quantitative HBsAg Levels in HBeAg-Positive Chronic Hepatitis B Patients

International Journal of Pharmaceutical Research ◽

10.31838/ijpr/2020.12.04.203 ◽

2020 ◽

Vol 12 (04) ◽

Keyword(s):

Chronic Hepatitis ◽

Liver Fibrosis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Transient Elastography ◽

Faculty Opinions recommendation of Mathematical modeling of triphasic viral dynamics in patients with HBeAg-positive chronic hepatitis B showing response to 24-week clevudine therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969232.793469134 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Mathematical Modeling ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Viral Dynamics ◽

Faculty Opinions recommendation of 52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717985040.793472617 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Efficacy And Safety ◽